共 50 条
- [3] The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy TRANSLATIONAL ONCOLOGY, 2022, 15 (01):
- [4] Enhanced therapeutic efficacy for glioblastoma immunotherapy with an oncolytic herpes simplex virus armed with anti-PD-1 antibody and IL-12 MOLECULAR THERAPY ONCOLOGY, 2024, 32 (02):